Free Trial

Haleon (HLN) Competitors

Haleon logo
GBX 390.50 +4.60 (+1.19%)
As of 02/21/2025 11:59 AM Eastern

HLN vs. ULVR, SGE, SN, WHR, ANP, CLX, TPX, PNPL, LEG, and BXP

Should you be buying Haleon stock or one of its competitors? The main competitors of Haleon include Unilever (ULVR), The Sage Group (SGE), Smith & Nephew (SN), Warehouse REIT (WHR), Anpario (ANP), Calnex Solutions (CLX), TPXimpact (TPX), Pineapple Power (PNPL), Legendary Investments (LEG), and Beximco Pharmaceuticals (BXP).

Haleon vs.

Haleon (LON:HLN) and Unilever (LON:ULVR) are both large-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their community ranking, institutional ownership, analyst recommendations, risk, profitability, media sentiment, dividends, valuation and earnings.

Haleon presently has a consensus price target of GBX 415, suggesting a potential upside of 6.27%. Unilever has a consensus price target of GBX 4,665, suggesting a potential upside of 6.10%. Given Haleon's stronger consensus rating and higher probable upside, research analysts clearly believe Haleon is more favorable than Unilever.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Haleon
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
Unilever
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50

43.9% of Haleon shares are owned by institutional investors. Comparatively, 54.4% of Unilever shares are owned by institutional investors. 10.7% of Haleon shares are owned by company insiders. Comparatively, 0.1% of Unilever shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Unilever has a net margin of 11.01% compared to Haleon's net margin of 9.66%. Unilever's return on equity of 34.57% beat Haleon's return on equity.

Company Net Margins Return on Equity Return on Assets
Haleon9.66% 6.54% 4.45%
Unilever 11.01%34.57%8.62%

Haleon has a beta of 0.19, suggesting that its share price is 81% less volatile than the S&P 500. Comparatively, Unilever has a beta of 0.22, suggesting that its share price is 78% less volatile than the S&P 500.

Haleon pays an annual dividend of GBX 6 per share and has a dividend yield of 1.5%. Unilever pays an annual dividend of GBX 147 per share and has a dividend yield of 3.3%. Haleon pays out 50.5% of its earnings in the form of a dividend. Unilever pays out 66.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Unilever has higher revenue and earnings than Haleon. Unilever is trading at a lower price-to-earnings ratio than Haleon, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Haleon£11.07B3.18£1.07B£11.8932.84
Unilever£70.72B1.84£7.79B£221.0919.89

In the previous week, Unilever had 2 more articles in the media than Haleon. MarketBeat recorded 3 mentions for Unilever and 1 mentions for Haleon. Haleon's average media sentiment score of 0.37 beat Unilever's score of -0.18 indicating that Haleon is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Haleon
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Unilever
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Unilever received 1003 more outperform votes than Haleon when rated by MarketBeat users. Likewise, 58.18% of users gave Unilever an outperform vote while only 29.73% of users gave Haleon an outperform vote.

CompanyUnderperformOutperform
HaleonOutperform Votes
11
29.73%
Underperform Votes
26
70.27%
UnileverOutperform Votes
1014
58.18%
Underperform Votes
729
41.82%

Summary

Unilever beats Haleon on 12 of the 19 factors compared between the two stocks.

Get Haleon News Delivered to You Automatically

Sign up to receive the latest news and ratings for HLN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HLN vs. The Competition

MetricHaleonDrug Manufacturers IndustryMedical SectorLON Exchange
Market Cap£35.24B£2.35B£5.84B£2.63B
Dividend Yield0.02%2.92%4.76%4.98%
P/E Ratio32.844.2718.26163.09
Price / Sales3.18733.09434.47312,084.14
Price / Cash21.9510.2538.4228.02
Price / Book2.157.507.645.14
Net Income£1.07B£20.70B£3.18B£5.73B
7 Day Performance1.61%0.03%-1.95%-0.99%
1 Month Performance5.14%0.15%-0.23%-0.81%
1 Year Performance19.60%98.05%16.69%39.25%

Haleon Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HLN
Haleon
0.4844 of 5 stars
GBX 390.50
+1.2%
GBX 415
+6.3%
+20.4%£35.24B£11.07B32.8425,408
ULVR
Unilever
1.0373 of 5 stars
GBX 4,380
-0.4%
GBX 4,665
+6.5%
+8.4%£129.34B£70.72B19.81148,000Insider Trade
SGE
The Sage Group
1.8418 of 5 stars
GBX 1,320.58
+0.4%
GBX 3,446.67
+161.0%
+10.9%£13.07B£2.14B51.3311,326Dividend Increase
News Coverage
SN
Smith & Nephew
3.7385 of 5 stars
GBX 1,025.50
-0.1%
GBX 4,607.50
+349.3%
-9.6%£11.24B£7.08B36.9218,452High Trading Volume
WHR
Warehouse REIT
3.4933 of 5 stars
GBX 84
-0.6%
GBX 108
+28.6%
+1.7%£355.84M£50.81M0.8161,000
ANP
Anpario
1.0501 of 5 stars
GBX 455.50
+2.0%
GBX 435
-4.5%
+97.0%£77.71M£33.50M25.15109High Trading Volume
CLX
Calnex Solutions
1.7102 of 5 stars
GBX 61.12
+0.6%
GBX 115
+88.2%
-26.7%£54.32M£16.52M1,352.229,000News Coverage
TPX
TPXimpact
N/AGBX 27.90
+1.5%
N/A-27.9%£25.33M£84.64M-1.2412,000
PNPL
Pineapple Power
N/AN/AN/AN/A£2.28MN/A-274.002High Trading Volume
LEG
Legendary Investments
N/AN/AN/AN/A£0.00N/A0.0019,900Gap Down
BXP
Beximco Pharmaceuticals
N/AGBX 39.30
+2.1%
N/A-7.3%£26.79B£7.08T4.225,500Gap Up

Related Companies and Tools


This page (LON:HLN) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners